Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJEFI.L Regulatory News (JEFI)

  • There is currently no data for JEFI

Update research from QuotedData

20 Jul 2021 11:01

RNS Number : 8319F
Jupiter Emerging & Frontier Inc.Tst
20 July 2021
 

Jupiter Emerging & Frontier Income - Update research from QuotedData

1st June 2021

 

Out in front

 

In both total net asset value (NAV) and share price return terms, Jupiter Emerging & Frontier Income (JEFI) has been the pacesetter within its peer group since the November 2020 vaccine announcements. Manager Ross Teverson and the team's long-held view that stocks were priced more attractively outside of China has been paying off, led by its Taiwan-based holdings in particular.

 

JEFI's bottom-up approach, which combines value and growth elements, has matched well with the shift away from growth stocks. A portfolio comprising predominantly of stocks with above-average dividend yields, the absence of reliance on China and India, and a mandate that allows investments into both emerging (EM) and frontier (FM) markets makes JEFI a unique proposition (see page 14). Despite its smaller size, it is trading at one of the tightest discounts within its peer group. A return to the pre-pandemic premium share price to NAV rating would allow JEFI to grow by raising capital and broaden its attraction to institutional investors.

 

Full research:

https://quoteddata.com/research/jupiter-emerging-frontier-income-front/

 

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note on Jupiter Emerging & Frontier Income Trust and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the FCA. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA123a Kings Road | London SW3 4PLTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAURRRRARUBUAR
Date   Source Headline
12th Apr 202210:37 amRNSNet Asset Value(s)
11th Apr 202211:15 amRNSNet Asset Value(s)
8th Apr 202210:07 amRNSNet Asset Value(s)
7th Apr 20229:49 amRNSNet Asset Value(s)
6th Apr 202210:54 amRNSNet Asset Value(s)
5th Apr 202212:17 pmRNSCompliance with Market Abuse Regulation
5th Apr 202210:19 amRNSNet Asset Value(s)
4th Apr 202212:59 pmRNSNet Asset Value(s)
1st Apr 202211:09 amRNSNet Asset Value(s)
31st Mar 20225:31 pmRNSTotal Voting Rights
31st Mar 202211:33 amRNSNet Asset Value(s)
30th Mar 202210:47 amRNSNet Asset Value(s)
29th Mar 202210:10 amRNSNet Asset Value(s)
28th Mar 20224:28 pmRNSHolding(s) in Company
28th Mar 20224:27 pmRNSResults of AGM
28th Mar 202210:20 amRNSNet Asset Value(s)
28th Mar 202210:00 amRNSChange of Fund Manager
25th Mar 202210:37 amRNSAGM Webcast joining instructions
25th Mar 202210:09 amRNSNet Asset Value(s)
24th Mar 202210:12 amRNSNet Asset Value(s)
23rd Mar 202210:19 amRNSNet Asset Value(s)
22nd Mar 202210:42 amRNSNet Asset Value(s)
21st Mar 202210:24 amRNSNet Asset Value(s)
18th Mar 202211:22 amRNSNet Asset Value(s)
17th Mar 202211:43 amRNSNet Asset Value(s)
16th Mar 202210:25 amRNSNet Asset Value(s)
15th Mar 202210:52 amRNSNet Asset Value(s)
14th Mar 20224:25 pmRNSPortfolio Update
14th Mar 202211:09 amRNSNet Asset Value(s)
11th Mar 202211:05 amRNSNet Asset Value(s)
10th Mar 20225:38 pmRNSAdjournment of General Meeting
10th Mar 202211:39 amRNSNet Asset Value(s)
9th Mar 202211:31 amRNSNet Asset Value(s)
8th Mar 20221:06 pmRNSCompany Update
8th Mar 202211:25 amRNSNet Asset Value(s)
7th Mar 202212:32 pmRNSNet Asset Value(s)
4th Mar 202211:12 amRNSNet Asset Value(s)
3rd Mar 20222:07 pmRNSUpdate on Russia Exposure
3rd Mar 202211:29 amRNSNet Asset Value(s)
2nd Mar 20222:57 pmRNSNet Asset Value(s)
1st Mar 20223:46 pmRNSNet Asset Value(s)
28th Feb 20225:28 pmRNSTotal Voting Rights
28th Feb 202210:58 amRNSNet Asset Value(s)
25th Feb 202211:24 amRNSNet Asset Value(s)
24th Feb 202210:45 amRNSNet Asset Value(s)
24th Feb 20227:00 amRNSUpdate on General Meeting
23rd Feb 202210:41 amRNSNet Asset Value(s)
22nd Feb 202211:20 amRNSNet Asset Value(s)
21st Feb 202210:53 amRNSNet Asset Value(s)
18th Feb 202210:17 amRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.